The Trump administration decided to put the pilot on hold until at least 2027.
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
Some health insurers are pushing back against a new program that will allow Medicare beneficiaries to pay $50 per month for ...
The Trump administration announced that it is indefinitely delaying the implementation of the Medicare Part D portion of the ...
In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new ...